Does Pneumocystis carinii prophylaxis still need to be lifelong?

New England Journal of Medicine

Volumn 340, Issue 17, 1999, Pages 1356-1358

  Masur, H ^a   Kaplan, J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ANTIBIOTIC PROPHYLAXIS; COMORBIDITY; DRUG WITHDRAWAL; EDITORIAL; FOLLOW UP; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TREATMENT PLANNING;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PNEUMONIA, PNEUMOCYSTIS; PRIMARY PREVENTION;

EID: 0033614479     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199904293401709     Document Type: Editorial

References (10)